Physician profile
Steven M Bailey
NPI 1700878436
$66,871.36
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $7,922 · 2021: $13K · 2022: $12K · 2023: $8,165 · 2024: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $19K · Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $19,326.95 |
| Food and Beverage | $126.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Choice Spine, LLC | $25,212.14 | 2019-2022 | |
| Integrity Implants INC. | $21,267.16 | 2019-2022 | Flarehawk, Linesider |
| Integrity Implants INC. Dba Accelus | $19,326.95 | 2023-2024 | Linesider |
| Penumbra, INC. | $234.54 | 2022 | |
| Medtronic USA, INC. | $179.98 | 2019-2020 | |
| Medtronic, INC. | $170.89 | 2021-2023 | Intellis Adaptivestim |
| Nevro Corp. | $150.57 | 2019-2020 | |
| Abiomed | $126.86 | 2019 | |
| Allergan, INC. | $101.22 | 2021 | |
| Tersera Therapeutics LLC | $32.46 | 2019 | |
| Providence Medical Technology, INC. | $22.11 | 2019 | |
| Boston Scientific Corporation | $18.25 | 2024 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $14.34 | 2022 | |
| Zimmer Biomet Holdings, INC. | $13.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.